Natalya N Pavlova - Publications

Affiliations: 
Memorial Sloan Kettering Cancer Center, Rockville Centre, NY, United States 
Area:
cancer genetics, cell metabolism

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Pavlova NN, Zhang J, Thompson CB. Abstract B39: Asparagine drives translational adaptation of cancer cells to glutamine deficit Cancer Research. 77. DOI: 10.1158/1538-7445.Transcontrol16-B39  0.311
2016 Pavlova NN, Thompson CB. Abstract A09: The role of asparagine in glutamine-independent proliferation of breast cancer cells Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Metca15-A09  0.319
2013 Pavlova NN, Pallasch C, Elia AE, Braun CJ, Westbrook TF, Hemann M, Elledge SJ. A role for PVRL4-driven cell-cell interactions in tumorigenesis. Elife. 2: e00358. PMID 23682311 DOI: 10.7554/Elife.00358  0.703
2013 Zhu J, Larman HB, Gao G, Somwar R, Zhang Z, Laserson U, Ciccia A, Pavlova N, Church G, Zhang W, Kesari S, Elledge SJ. Protein interaction discovery using parallel analysis of translated ORFs (PLATO). Nature Biotechnology. 31: 331-4. PMID 23503679 DOI: 10.1038/Nbt.2539  0.678
2013 Solimini NL, Liang AC, Xu C, Pavlova NN, Xu Q, Davoli T, Li MZ, Wong KK, Elledge SJ. STOP gene Phactr4 is a tumor suppressor. Proceedings of the National Academy of Sciences of the United States of America. 110: E407-14. PMID 23319639 DOI: 10.1073/Pnas.1221385110  0.594
2013 Pavlova NN, Pallasch C, Elia AE, Braun CJ, Westbrook TF, Hemann M, Elledge SJ. Author response: A role for PVRL4-driven cell–cell interactions in tumorigenesis Elife. DOI: 10.7554/Elife.00358.038  0.634
2013 Davoli T, Solimini NL, Pavlova NN, Xu Q, Mengwasser K, Sack LM, Liang AC, Schlabach MR, Luo J, Burrows AE, Anselmo AN, Li MZ, Elledge SJ. Abstract IA28: Haploinsufficiency in cancer Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-Ia28  0.72
2013 Solimini N, Pavlova NN, Mermel C, Xu Q, Burrows AE, Luo J, li M, Beroukhim R, Meyerson M, Elledge SJ. Abstract SY25-03: Haploinsufficiency in cancer: When half simply isn't good enough. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Sy25-03  0.683
2012 Larman HB, Xu GJ, Pavlova NN, Elledge SJ. Construction of a rationally designed antibody platform for sequencing-assisted selection Proceedings of the National Academy of Sciences of the United States of America. 109: 18523-18528. PMID 23064642 DOI: 10.1073/Pnas.1215549109  0.658
2012 Solimini NL, Bredemeyer AL, Li MZ, Beroukhim R, Meyerson M, Elledge SJ, Pavlova NN, Xu Q, Mermel CH, Liang AC, Schlabach MR, Luo J, Burrows AE, Anselmo AN. Abstract IA8: Genetic approaches to cancer Cancer Research. 72. DOI: 10.1158/1538-7445.Csb12-Ia8  0.607
2011 Sun T, Aceto N, Meerbrey KL, Kessler JD, Zhou C, Migliaccio I, Nguyen DX, Pavlova NN, Botero M, Huang J, Bernardi RJ, Schmitt E, Hu G, Li MZ, Dephoure N, et al. Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase. Cell. 144: 703-18. PMID 21376233 DOI: 10.1016/J.Cell.2011.02.003  0.721
2010 Sun T, Meerbrey K, Kessler J, Botero M, Migliaccio I, Nguyen D, Pavlova N, Bernardi R, Schmitt E, Hilsenbeck S, Creighton C, Shaw C, Gibbs R, Wheeler D, Osborne C, et al. Abstract S6-10: Identification of a Novel Tumor Suppressor Network Reveals a Role for Proto-Oncogenic Receptor Tyrosine Kinases in Triple-Negative Breast Cancer Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-S6-10  0.617
2008 Mulligan P, Westbrook TF, Ottinger M, Pavlova N, Chang B, Macia E, Shi YJ, Barretina J, Liu J, Howley PM, Elledge SJ, Shi Y. CDYL Bridges REST and Histone Methyltransferases for Gene Repression and Suppression of Cellular Transformation Molecular Cell. 32: 718-726. PMID 19061646 DOI: 10.1016/J.Molcel.2008.10.025  0.674
2008 Westbrook TF, Hu G, Ang XL, Mulligan P, Pavlova NN, Liang A, Leng Y, Maehr R, Shi Y, Harper JW, Elledge SJ. SCFβ-TRCP controls oncogenic transformation and neural differentiation through REST degradation Nature. 452: 370-374. PMID 18354483 DOI: 10.1038/Nature06780  0.677
2007 Cinar B, Fang PK, Lutchman M, Di Vizio D, Adam RM, Pavlova N, Rubin MA, Yelick PC, Freeman MR. The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1. The Embo Journal. 26: 4523-34. PMID 17932490 DOI: 10.1038/Sj.Emboj.7601872  0.353
Show low-probability matches.